This is a success message.
This is an error message.
This is also an error message.
Company news

Congratulations to Dr. Samuel Katz, Recipient of the LUMICKS Cell Avidity Travel Award

October 13, 2026

We are delighted to announce that Samuel Katz, MD, PhD from Yale School of Medicin has been selected as the recipient of the LUMICKS 2026 SITC Cell Avidity Travel Award.

Dr. Katz was recognized for their innovative research leveraging Cell Avidity measurements to better understand CAR-T Therapy in Solid Tumors. Their work will be presented at SITC 2026 Annual Meeting, where they will share new insights with the scientific community.

‍

Poster Title: Nanobody engineering overcomes key barriers to MET CAR-T cell therapy in solid tumors

Abstract Number: 128

‍

The LUMICKS Cell Avidity Travel Award supports researchers who are advancing Cell Avidity science and helping expand our understanding of immune cell function, cell therapies, and therapeutic development.

Congratulations, Dr. Samuel Katz, and thank you for advancing Cell Avidity research!

“Cell Avidity profiling with the LUMICKS z-Movi system allowed us to directly measure the physical binding strength between our nanobody CAR-T constructs and tumor target cells. We found that avidity did not correlate linearly with cytotoxic potency. The highest-avidity constructs did not mediate the strongest tumor killing, suggesting that avidity above a certain functional threshold is sufficient, while further increases may not improve and could even reduce killing efficiency. Overall, avidity profiling added a valuable biophysical dimension to our multi-platform characterization of CAR-T function, complementing our cytotoxicity and cytokine assays.”

Samuel Katz, MD, PhD
Yale School of Medicine

Latest news & press

Keep up with everything we’re doing

View all
Congratulations to Dr. Samuel Katz, Recipient of the LUMICKS Cell Avidity Travel Award
Congratulations to Dr. Samuel Katz, Recipient of the LUMICKS Cell Avidity Travel Award
Company news
October 13, 2026
01-01-20

This is some text inside of a div block.
author empty
application empty
October 13, 2026
LUMICKS is collaborating with Amgen to measure Cell Avidity to better understand T-cell engagers
LUMICKS is collaborating with Amgen to measure Cell Avidity to better understand T-cell engagers
Company news
September 30, 2026
01-01-20

This is some text inside of a div block.
author empty
application empty
September 30, 2026
LUMICKS Receives Innovation Champion Award at TechEU Equity Summit 2026
LUMICKS Receives Innovation Champion Award at TechEU Equity Summit 2026
Company news
September 25, 2026
01-01-20

This is some text inside of a div block.
author empty
application empty
September 25, 2026
2026 SITC Cell Avidity Travel Award
2026 SITC Cell Avidity Travel Award
Company news
July 27, 2026
01-01-20

This is some text inside of a div block.
author empty
application empty
July 27, 2026
See more. Know more.
All products and technologies are for Research Use Only (RUO) except when specifically noted
Cookie preferences
Privacy policy
Immuno-oncology

Technology hub

Cell Avidity

Applications

Cell Therapy
Cell Engagers
Antibody Therapy

Solutions

Avidion
z-Movi
Avidigo services

Resources

Knowledge library
Publications

Exclusives

Avidion Early Access
Molecular biology

Technology hub

Dynamic Single-Molecule

Applications

DNA-Binding proteins
Protein Folding
Phase Separation
Mechanobiology
Cytoskeletal Structure and Transport

Solutions

C-Trap
Consumables & reagents

Resources

Knowledge library
Publications
LUMICKS University
LUMICKS University
Company
About us
Life at LUMICKS
Careers

News & events

News & Press
Events
Contact

Email

info@lumicks.com